
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.260 | 0.260 | 0.000 |
Shares | 99.740 | 99.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.865 | 19.721 |
Price to Book | 3.016 | 3.900 |
Price to Sales | 2.534 | 2.233 |
Price to Cash Flow | 10.095 | 14.997 |
Dividend Yield | 3.066 | 1.495 |
5 Years Earnings Growth | 5.892 | 9.862 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 8.09 | 96.02 | +2.08% | |
Roche Holding Participation | CH0012032048 | 7.62 | 246.30 | -0.04% | |
AstraZeneca | GB0009895292 | 6.98 | 11,036.0 | +1.04% | |
J&J | US4781601046 | 6.90 | 173.82 | +0.28% | |
Merck&Co | US58933Y1055 | 5.15 | 80.03 | -0.82% | |
Bayer | DE000BAY0017 | 4.78 | 25.71 | 0.00% | |
Gilead | US3755581036 | 4.00 | 120.54 | +0.95% | |
Chugai Pharmaceutical | JP3519400000 | 3.92 | 6,092.0 | -17.68% | |
Takeda Pharmaceutical | JP3463000004 | 3.80 | 4,265.0 | +0.83% | |
GSK plc | GB00BN7SWP63 | 3.76 | 1,404.00 | +0.61% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 654.16M | -5.39 | 4.00 | 9.13 | ||
Seligson & Co Global Top 25 Brands | 654.16M | -5.38 | 4.01 | 9.09 | ||
FI4000283031 | 613.57M | -2.46 | 15.23 | - | ||
Seligson & Co North American A | 555.82M | 0.41 | 14.73 | 13.26 | ||
Seligson North American B | 555.82M | 1.16 | 15.01 | 13.33 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review